The Effects of Different Repeated Doses of Entacapone on the Pharmacokinetics of L-Dopa and on the Clinical Response to L-Dopa in Parkinson's Disease
Helena Heikkinen(Orion Corporation (Finland)), Ariel Gordin(Orion Corporation (Finland)), William C. Koller(Stanford University), John G. Nutt(Oregon Health & Science University), Peter A. LeWitt(Wayne State University)
Cited by 49
Related Papers
Variable expression of Parkinson's disease
|Neurology|1990|1.3k
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
|Movement Disorders|2006|1.1k
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
|The American Journal of Human Genetics|2003|537
High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor
|Annals of Neurology|1997|484